Author

Ana Rita Pedroso

Observed name: A.R. Pedroso

Institution: Unidade Local de Saúde de Braga

Observed institutions: Hospital Braga, Unidade Local de Saúde de Braga

OpenAlex ID: A5111149954

The CheckMate 816 trial: a milestone in neoadjuvant chemoimmunotherapy of nonsmall cell lung cancer

2024 · Marie Mayenga, Ana Rita Pedroso, et al. · Breathe · 7

Predictive factors for dose reduction and discontinuation of nintedanib in fibrotic interstitial lung diseases: Real life data

2024 · Emanuel Costa, Ana Rita Pedroso, et al. · Respiratory Medicine · 7

ERS Congress 2024: highlights from the Thoracic Oncology Assembly

2025 · Maria Joana Pereira Catarata, Sheetal Chaurasia, et al. · ERJ Open Research · 4

Ab1442 Predictive Factors for Dose Reduction and Discontinuation of Nintedanib in Fibrotic Interstitial Lung Diseases: a Real-life, Single-center Study

2024 · C. Ferreira, E. Costa, et al. · Annals of the Rheumatic Diseases · 1

Works count: 4

Citation count: 19

H-index: 3

I10-index: